| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
NEUROPEPTIDE Y (13-36) (PORCINE)
|
113662-54-7 |
PRO-ALA-GLU-ASP-LEU-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
NEUROPEPTIDE Y (13-36) (PORCINE);NEUROPEPTIDE Y FRAGMENT 13-36 PORCINE;NEUROPEPTIDE Y (PORCINE, 13-36) (BOVINE);NPY (PORCINE, 13-36)(BOVINE);NPY (13-36) (PORCINE);NPY 13-36;PRO-ALA-GLU-ASP-LEU-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;PAEDLARYYSALRHYINLITRQRY-NH2
|
C135H209N41O36 |
2982.36 | |
|
Gap 26
|
197250-15-0 |
GAP26
|
GAP-26;GAP26
|
C70H107N19O19S |
1550.78 | |
|
(-)-MK 801 maleate
|
77086-19-2 |
(-)-MK 801 顺丁烯二酸盐
|
(-)-MK 801 顺丁烯二酸盐;(5S,10R)-()-5-甲基-10,11-二氢-5H-二苯并[A,D]环庚烯-5,10-亚胺氢化马来酸盐
|
C16H15N.C4H4O4 |
337.36916 | |
|
IFENPRODIL HEMITARTRATE
|
23210-58-4 |
酒石酸艾芬地尔
|
酒石酸艾芬地尔;苄哌酚胺;&ALPHA-(4-HYDROXYPHENYL)-&BETA-METHYL-4-(PHENYLMETHYL)-1-PIPERIDINEETHANOL (2R;3R)-2;3-DIHYDROXYBUTANEDIOATE;IFENPRODIL L-(+)-TARTRATE;RC-61-91;CEROCRAL;DILVAX;VADILEX;洒石酸艾芬地尔;4-苄基-1-[BETA,4-二羟基-ALPHA-甲基苯乙基]哌啶酒石酸盐 (2:1)
|
C21H27NO2.C4H6O6 |
475.53142 | 245-493-5 |
|
FPL 64176
|
120934-96-5 |
2,5-DIMETHYL-4-[2-(PHENYLMETHYL)BENZOYL]-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER
|
|
C22H21NO3 |
347.40704 | |
|
Flumazenil
|
78755-81-4 |
氟马西尼
|
氟马西尼;氟马泽尼;氟马西尼;氟马泽尼(标准品);FLUMAZENIL;RO 15-1788;RO15-1788;福马西尼;氟马泽尼;氟马西林;安易醒;8-氟-5,6-二氢-5-甲基-6-氧代-4H-咪唑并[1,5-Α][1,4]苯并二氮杂卓-4-羧酸乙酯
|
C15H14FN3O3 |
303.29 | 616-650-9 |
|
QUISQUALIC ACID
|
52809-07-1 |
(+)使君子氨酸
|
使君子氨酸;L-使君子氨酸;Β-(3,5-二氧代-1,2,4-氧杂重氮烷-2-基)-L-丙氨酸;(+)使君子氨酸;使君子氨酸;()-QUISQUALIC ACID;(+)使君子氨酸;使君子酸
|
C5H7N3O5 |
189.12618 | |
|
L-152,804
|
6508-43-6 |
L 152804
|
|
C23H26O4 |
366.45014 | |
|
Amyloid b-Peptide (12-28) (human)
|
107015-83-8 |
淀粉-Β-蛋白片段12-28
|
淀粉-Β-蛋白片段12-28
|
C89H135N25O25 |
1955.1767 | |
|
CGP 52432
|
139667-74-6 |
4-苄氧基苯基异硫氰酸酯
|
CGP 52432;CGP-52432;CGP 52432;3-[(3,4-二氯苯基)甲基氨基]丙基-(二乙氧基甲基)次膦酸
|
C15H24NO4PCl2 |
384.23516 | -0 |
|
MPEP
|
96206-92-7 |
MPEP
|
2-甲基-6-(苯乙炔)吡啶盐酸盐;2-甲基-6-(苯基乙炔基)吡啶;CS-715;MPEP 100MG
|
C14H11N.HCl |
229.70478 | |
|
2-METHYLTHIOADENOSINE TRIPHOSPHATE TETRASODIUM
|
43170-89-4 |
中文名称暂缺
|
|
C11H14N5O13P3S-4.4[Na+] |
641.20016 | |
|
1,4-Benzodioxan
|
493-09-4 |
1,4-苯并二恶烷
|
1,2-乙烯基二氧苯;1,4-苯并二烷;1,4-苯并二恶烷;1,4-苯并二【口+咢】烷;1,4-苯并二噁烷;1,4-苯并二氧六环;1,4-苯并二烷,97%;1,4-苯并二口恶烷
|
C8H8O2 |
136.15 | 207-775-6 |
|
(+)-Cloprostenol
|
54276-21-0 |
(+)-氯前列烯醇
|
氯前列醇杂质;氯前列烯醇;(+)-氯前列烯醇;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-氯苯氧基)-3-羟基-1-丁烯-1-基]-3,5-二羟基环戊基]-5-庚烯酸;(+)-氯前列醇;10%D-氯前列醇乙醇溶液
|
C22H29CLO6 |
424.92 | 255-028-8 |
|
PACOCF3
|
141022-99-3 |
1,1,1-三氟-2-十七烷酮
|
1,1-三氟-2-十七烷酮
|
C17H31OF3 |
308.42264 | |
|
Ketanserin tartrate
|
83846-83-7 |
酒石酸酮色林
|
酮舍林酒石酸盐(标准品);酒石酸酮色林;酮色酒石酸;酮舍林酒石酸盐;酒石酸酮舍林;酒石酸酮色啉盐
|
C26H28FN3O9 |
545.51 | 281-062-8 |
|
L-694,247
|
137403-12-4 |
L-694,247
|
2-[5-[3-(4-METHYLSULFONYLAMINO)BENZYL-1,2,4-OXADIAZOL-5-YL]-1H-INDOL-3-YL]ETHANAMINE;2-[5-[3-(4-METHYLSULPHONYLAMINO)BENZYL-1,2,4-OXADIAZOL-5-YL]-1H-INDOL-3-YL] ETHANAMINE;L-694,247;N-[4-[[5-[3-(2-Aminoethyl)-1H-indol-5-yl]-1,2,4-oxadiazol-3-yl]methyl]phenyl]-methanesulfonamide;3-benzyl-5-(1H-indol-3-yl)-1,2,4-oxadiazole;N-(4-((5-(3-(2-Aminoethyl)-1H-indol-5-yl)-1,2,4-oxadiazol-3-yl)methyl)phenyl)methanesulfonamid
|
C20H21N5O3S |
411.47744 | |
|
Eledoisin-Related Peptide
|
2990-43-4 |
LYS-PHE-ILE-GLY-LEU-MET-NH2
|
|
C34H58N8O6S |
706.94 | |
|
H-MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS-OH
|
149635-73-4 |
髓鞘少突胶质细胞糖蛋白
|
髓鞘少突胶质细胞糖蛋白;H-MEVGWYRSPFSRVVHLYRNGK-OH;MET-GLU-VAL-GLY-TRP-TYR-ARG-PRO-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS;MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS: MEVGWYRSPFSRVVHLYRNGK;髓鞘少突胶质细胞糖蛋白 149635-73-4
|
C118H177N35O29S |
2581.95 | |
|
(2S,1'S,2'S)-2-(CARBOXYCYCLOPROPYL)GLYCINE
|
117857-93-9 |
中文名称暂缺
|
|
C6H9NO4 |
159.13996 |
药智官方微信
药智官方微博
